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Candidates for future development of premature coronary heart disease 
(CHD) can now be identified with a degree of probability unsurpassed for 
most other diseases, and equaled for few. This remarkable achievement has 
not come about fortuitously, but through the deliberate planning of long-term 
epidemiological studies. 
The ultimate purpose of defining risk in quantitative terms is the identifica- 
tion of susceptibles in the community, in order to institute ereventive mea- 
sures. The predictability of coronary disease in middle age from simple risk 
factor measurements provides an invaluable scientific base for curbing the 
contemporary epidemic of this preeminent chronic disease. The eventual 
elimination of this epidemic demands, in addition to identification and care of 
susceptibles, changes in the mode of life in the national community at large 
(la. 
HYPERCHOLESTEROLEMIA, HYPERTENSION, AND CIGARETTE SMOKING 
The three risk factors - hypercholesterolemia, hypertension and cigarette 
smoking- have not been “discovered” through epidemiological studies. 
Rather, clinicians and researchers have known or suspected for a long time 
that they play an etiological role in coronary heart disease. Epidemiological 
investigations have proven the associations and put them into quantitative 
terms. These three predictors 
are properly designated major risk factors for premature atherosclerotic dis- 
ease, especially coronary disease. This designation is appropriate, first because of 
the impact of these factors on risk, particularly when present in combination, second 
because of the consistency of the findings from multiple studies, and third because 
of the frequency of occurrence of these factors singly and in combination in 
the American population. All three are potentially amenable to prevention and 
control (1). 
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FIG. 1. National cooperative Pooling Project; serum cholesterol level at entry and lo-year age- 
adjusted rated per 1,000 men for: any major coronary event, sudden death (la); any coronary 
death, death from all causes (lb). Any major coronary event includes nonfatal MI, fatal MI, sud- 
den death due to CHD; U. S. white males age 30-59 at entry; all rates age-adjusted by lo-year age 
groups to the U. S. white male population, 1960 (6,6a-1). 
Of course, these three are not the only coronary risk factors, and in a given 
individual others may assume greater importance. However, no other vari- 
ables presently known are equally effective in population groups for iden- 
tifying persons prone to develop manifest disease over the next 5 or 10 years. 
That is, these three factors, in combination, concentrate the majority of 
subsequent new events of coronary disease among a minority of the popula- 
tion at risk. Their preeminence as predictors is confirmed by multivariate 
analysis (see below), using a series of additional factors and testing their rela- 
tive importance by a modified form of discriminant analysis (l-7). 
In Figs, 1-3, the three variables have first been treated singly.2 In agree- 
* These are preliminary data from the national cooperative Pooling Project (6,6a-1). In this Proj- 
ect, data on risk factors collected at initial examination, and IO-year follow-up data on disease in- 
cidence and mortality, have been pooled from several major U. S. prospective studies. The base 
population for the figures presented here is derived from five studies, and numbers 7,594 white 
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ment with the findings from most U. S. prospective studies, risk of developing 
premature CHD-including sudden death and all fatal CHD - increases as 
the serum cholesterol rises (Fig. la&) (1). Since CHD is the single most im- 
portant cause of death, mortality from all causes is also related to choles- 
terolemia. For first major coronary events (nonfatal and fatal myocardial in- 
farction plus sudden deaths attributed to CHD), there is an almost fourfold 
gradient in risk between those at opposite ends of the range, below 175 and 
above 299 mg/dl. There are fewer than 10% of the men in these two cat- 
egories. Note that almost half of the new events (286 out of 596) occur among 
the third of the men with levels of 250 mg/dl or above. Note also that this 
upper third had a level of serum cholesterol carrying a lo-year CHD risk 
about twice as high as that seen among the remainder of the population 
(119/1000 as opposed to 61). 
The findings for blood pressure and these same end points are similar (Fig. 
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FIG. 2. National cooperative Pooling Project; diastolic blood pressure level at entry and IO-year 
age-adjusted rates per 1,000 men for: any major coronary event and sudden death (2a); any 
coronary death, stroke death, death from all causes (2b). Any major coronary event includes non- 
fatal MI, fatal MI, sudden death due to CHD; U. S. white males age 30-59 at entry; all rates age- 
adjusted by lo-year age groups to the U. S. white male population, 1960 (6,6a-1). 
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2~,b) (1). While Fig. 2 deals only with diastolic pressure, essentially the same 
results are available for systolio pressure. Compared to optimal levels of blood 
pressure, even “modest” elevations (i.e., diastolics of 85-94 or 95-104 mm 
Hg) are associated with gross increases in risk-a point of great practical sig- 
nificance for clinicians. 
TO put this important observation in a more general way, for each of these 
quantitative variables, there is a steady increment in risk as level of the vari- 
able rises. As cholesterol concentration - or blood pressure-increases, risk 
increases. The relationships are continuous. There is no evidence of a critical 
level which divides “normal” subgroups (i.e., subgroups “immune” to prema- 
ture coronary heart disease) from CHD-prone “abnormal” subgroups. For 
individuals, this conclusion- from the massive epidemiologic data can be 
reformulated as follows: The higher the risk factor level, the greater the prob- 
ability for an individual of developing coronary disease. This is important 
from the point of view of instituting preventive measures. The greater the 
probability, the greater the need for prophylaxis-but there is no single 
“screening level” separating those in need of prophylaxis from those who are 
not. 
This basic set of conclusions does not negate-but rather places in proper 
context- the clinical use of practical cutting points, e.g., serum cholesterol of 
less than 200 mg/dl as normal; 200-249 as borderline, 250 or greater as ab- 
normal. As American Heart Association statements on risk factors have em- 
phasized, this 250 mg/dl level for defining hypercholesterolemia is approxi- 
mately the 2 to 1 cutting point, i.e., persons positive for this risk factor are 
approximately twice as susceptible to premature CHD as those with lower 
levels (everything else being equal). The impact of these factors is no small 
lo%, but rather 100% -a doubling of risk. But as useful as this practical 
approach of cutting points is, it remains a distortion of reality. ‘After all, a 
person with a serum cholesterol of 240 is at greater risk than one at 210 and he 
in turn is at greater risk than one at 160. How then to make use of all the quan- 
titative information in clinical and public health practice? New methods of 
statistical evaluation do in fact make this possible (see below). 
As for cigarette smoking, massive studies in the United States have repeat- 
edly shown that any regular use of cigarettes is associated with increased risk 
of CHD (Fig. 3a,b) (1). However, the risk for ex-cigarette smokers is about the 
same as for those who never smoked. The practical implications are obvious: 
Don’t smoke cigarettes, or-if a current smoker-quit while still ahead, i.e., 
still free of CHD. It pays! 
For those regularly smoking cigarettes when first examined, risk rose stead- 
ily with number of cigarettes smoked per day (Fig. 3). Once again, the rela- 
tionship is quantitative and continuous. The gradient is twofold between 
those who smoke a pack or less and those smoking more than a pack. A “dose- 
response ” relationship of this kind is one piece of evidence in favor of a causa- 
tive relationship. (Another is the consistent finding in several postmortem 
studies that coronary atherosclerosis was more severe in persons who had 
smoked cigarettes than in non-cigarette users.) Note in Fig. 3 that 60% of the 
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FIG. 3. National cooperative Pooling Project; smoking status at entry and lo-year age-adjusted 
rates per 1,000 men for: any major coronary event, sudden death, any coronary death, death from 
all causes: any major coronary event includes nonfatal MI, fatal MI, sudden death due to CHD; 
U. S. white males age 30-59 at entry; all rates age-adjusted by lo-year age groups to the U. S. white 
male population, 1960. Graphs present smoking status at entry and the lo-year age-adjusted rates, 
irrespective of other risk factors (6,6a-1). 
men are cigarette smokers. They account for no less than 431 out of the 589 
new events (73.2%)! It will be most interesting to have a clinical look at the 53 
non-smokers (never smoked) with new events. How many of them had high 
serum cholesterol and/or blood pressure ? This last question highlights the 
need to look at combinations of risk factors simultaneously, as shown next. 
In Fig. 4a-d, the three risk factors are arranged in various combinations, in 
order to assess their additive or synergistic predictive power (1). In this 
display, a single cutting point has reluctantly been used to separate “high” 
from “not high” levels. (N. B.: “Not high” is not equal to low or optimal-at 
least not for serum cholesterol and diastolic pressure, as is evident from the 
cutting points of 250 mg/dl and 90 mm Hg, respectively.) In view of what has 
just been said, this approach is arbitrary and undesirable. However, such anal- 
yses would become impossibly complex if the variables were quantitated at 
several. levels. As long as this limitation is kept in mind, looking at combina- 
tions of risk factors in this way is useful and informative. As already noted, 
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newer biomathematical techniques, specifically multivariate risk functions 
(see below), obviate these problems by treating risk factors as continuous, 
strictly quantitative variables. However, this approach has not yet been 
translated into clinical terms. There is a place, therefore, for both kinds of 
display. 
In Figs. 4a and b, the entire group of 7,342 Pooling Project men are divided 
into six of eight possible subgroups. This permits evaluation of the indepen- 
dent and additive effect of cigarette smoking. Thus, when the 2,018 men with 
cigarette smoking as the only risk factor are compared with the 1,249 men 
FIRSTMAJOR CORONARY EVENT SUDDEN DEATH 
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;;;yH ';,"H"' CtH ",;" 
N,;e;t;of 28 97 74 167 31 82 8 25 24 61 5 26 
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FIG. 4a,b. National cooperative Pooling Project; smoking status at entry and IO-year age-ad- 
justed rates per 1,000 men for: any major coronary event, sudden death, any coronary death, death 
from all causes; any major coronary event includes non-fatal MI, fatal MI, sudden death due to 
CHD; U. S. white males age 30-59 at entry; all rates age-adjusted by lo-year age groups to the 
U. S. white male population, 1960. Graphs present rates for non-cigarette smokers vs. cigarette 
smokers at entry, with simultaneous control of blood pressure and serum cholesterol level; for 
this analysis, the following cutting points were used: cigarette smoking (S) any use at entry, 
serum cholesterol (C) 2 250 mg/dl, diastolic blood pressure (H) > 90 mm Hg (6,6a-1). 
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FIG. 4c,d. National cooperative Pooling Project; hypercholesterolemia, hypertension, cigarette 
smoking and IO-year age-adjusted rates per 1,000 men for: any major coronary event, sudden 
death (4c), any coronary death, death from all causes (4d); an y ma or coronary event includes non- j 
fatal MI, fatal MI, sudden death due to CHD; U. S. white males, age 30-59 at entry; all rates age- 
adjusted by IO-year age groups to the U. S. white male population, 1960 (6,6a-1). 
with none of the three risk factors, the lo-year rates of first major coronary 
events are 45 and 20 per 1,000, respectively. Cigarette smoking is associated 
with a more than twofold increase in risk. The situation is similar for the other 
two paired comparisons -cigarette smokers vs. non-cigarette smokers, with 
one other risk factor (1,794 and 1,302 men, respectively); cigarette smokers vs. 
non-cigarette smokers, with two other risk factors (595 and 384 men, respec- 
tively). Moreover, cigarette smoking consistently makes an independent and 
additive contribution to risk of sudden death, coronary death, and death from 
all causes. 
Similar analyses also demonstrate that serum cholesterol and blood pres- 
sure-like cigarette smoking- each make an independent and additive con- 
tribution to risk. 
In Fig. 4c and d, the same data are again displayed, in simpler form, so that 
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the three risk factors are not distinguished one from the other. Once again it is 
worth noting: the analysis is a crude one, in that each man is characterized 
only on the basis of a single measurement of each risk factor at the entry exam- 
ination, and his status with respect to each factor is arrived at by dichotomiza- 
tion (high or not high). Nevertheless the subgroups were very different in 
their lo-year morbidity and mortality experience. Presence of only one risk 
factor-as compared to none-was associated with a substantial increase 
(2.4-fold, or 140%) in probability of a major coronary event over the next dec- 
ade. Increase in risk of a fatal event, including total mortality, was almost 
double. For the men with any two of the risk factors, risk of a major event was 
increased more than fourfold; risk of death, more than threefold. For the men 
with all three factors, risk of a major event was increased more than eightfold; 
risk of death, fivefold. This is indeed powerful prediction from three simple 
variables, measured once, and simply dichotomized- far more powerful 
prediction than is available for most other diseases, acute or chronic! 
Note further the typical American situation, product of our way of life: only 
1,249 of the 7,342 white males age 30-59 at entry- i.e., only 17% -were clas- 
sified not high for all three factors. All the rest had one or more risk factors: 
45% with one, ‘30% with two, 8% with all three. These latter two subgroups, 
with any two or all three risk factors (38% of the total group), accounted for 
58% of first major coronary events, 62% of sudden deaths, 57% of coronary 
deaths, 55% of.all deaths. 
Obviously it is appropriate to designate persons with such combinations of 
these traits as very high risk individuals, very prone to premature atheros- 
clerotic disease. Obviously too, especially since a first event is so often a 
catastrophic one (25% are sudden deaths), it is very sound strategy to detect 
such very high risk men as early in young adulthood and middle age as pos- 
sible, and to as$st them preventively by bringing about sustained correction 
of their risk fa 
7 
ors, by safe well-tested means- nutritional for hypercholes- 
terolemia, hygienic for cigarette smoking, nutritional (weight control and 
moderate salt restriction) plus pharmacologic (when necessary) for hyperten- 
sion. 
A halfing of the CHD mortality rate by such means in the subgroup of 
Pooling Project men with any two or all three of these risk factors-a reason- 
able goal, from a rate 4 times that of the subgroup with no risk factors to a rate 
still twice as high-would have saved 72 lives. For the entire Pooling Project 
group of 7,342 men, this would have meant a reduction in CHD mortality rate 
of 29% -and a reduction in mortality rate from all causes of 13%. Project this 
to the U. S. population of young and middle-aged male adults as a 
whole- with almost 150,000 coronary deaths per year prior to age 65. The 
saving would be 40,000 lives per year! The reduction in total mortality rate 
would be about equal to that achieved for adult males by all other means since 
1900! This is the meaning- this is the stake-in the “risk factor story”! 
PREDICTING RISK FROM MULTIVARIATE FUNCTION 
As already noted, serious limitations exist in the cross-classification method 
for evaluating impact of combinations of risk factors. When only three factors 
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are considered simultaneously and each is crudely evaluated by simple dicho- 
tomization, as above, the population at risk is divided into eight groups. When 
four variables are simultaneously considered in a similar fashion, the number 
of cells increases to 16; with five variables, to 32. Under these analytical cir- 
cumstances, several cells become too small in size, even with quite a large 
population available for study, as in the Pooling Project. Moreover, dicho- 
tomization - by treating each and every level of a risk factor as either high or 
not high-utilizes quantitative data in the most crude and meager fashion, 
rather than taking full advantage thereof. 
In recent years, several statistical methods for multivariate analysis-some 
of them newly developed- have been applied to this problem. In 1967, data 
utilizing one such method-the multiple logistic model-were published 
from the Framingham study, based on the risk factor findings at first examina- 
tion and 12-year CHD incidence (3). This method made it possible to com- 
pute a risk probability for each individual based on simultaneous evaluation 
of his several findings, e.g., serum cholesterol, blood pressure, smoking habit, 
etc. 
For this purpose, use was made of the statistical method of linear discrimi- 
nant function to estimate coefficients for several risk factors considered simul- 
taneously. The coefficients were obtained using the observed data from the 
Framingham population on risk factor levels and 12-year CHD incidence. 
TABLE I 
LINEAR DISCFUMINANT FUNCTION COEFFICIENTS (p) AND CONSTANT (a), MEN AND 
WOMEN, AGE 30-62 AND FREE OF CHD AT ENTRY, BASED 
ON 12-YEAR FOLLOW-UP DATA ON CHD INCIDENCE, 
THE FRAMINGHAM STUDY (3) 
Risk factors (x’s) 2,187 Men 






















0.0708 0.0083 0.0765 0.0133 
0.0105 0.0016 0.0061 0.0021 
0.0166 0.0036 0.0221 0.0043 
0.0138 0.0051 0.0053 0.0054 
-0.0837 0.0542 0.0355 0.0844 
0.3610 0.0587 0.0766 0.1158 
1.0459 0.2706 1.4338 0.4342 
-10.8986 - - 12.5933 - 
’ Coded 0 as: = never smoked; 1 = < pack/day; 2 = 1 pack/day; 3 pack/day. = > 
’ Coded as: 0 for normal; 1 for definite or possible LVH. definite nonspecific abnormality and 
intraventricular block. 
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TABLE II 
EXPECTEDANDOBSERVEDNUMBEROF CASES OF CHDAND 
OBSERVED~NCIDENCEIN ~~YEARSOF FOLLOW-UP, 
MENANDWOMENAGE~O-~~ANDFREEOF CHD ATENTRY, 
THE FRAMINGHAM STUDY (3) 
2,187 Men 2,669 Women 
Observed Observed 
Decile of Risk No. of No. of 12-year No. of No. of 12-year 
calculated from cases cases incidence cases cases incidence 
multiple logistic expected observed (per 1,000) expected observed (per 1,000) 
1 3.4 0 0 1.1 1 4 
2 6.0 3 14 1.7 3 11 
3 8.6 10 46 2.3 0 0 
4 11.5 13 59 3.2 2 7 
5 15.0 20 91 4.4 6 22 
6 19.7 22 101 6.5 5 19 
7 25.0 33 151 9.8 14 52 
8 32.6 31 142 15.0 21 79 
9 47.1 44 201 24.7 23 86 
10 90.5 82 375 70.4 54 202 
All 259.4 258 118 139.1 129 48 
The coefficients for males and females age 30-62 at entry are presented in 
Table I. The value for CHD risk y for each individual was then computed ac- 
cording to the formula: 
y = l/[l + e - (a+hm+Pz22. . Pm)] 
where e is the base for natural or Naperian logarithms, i.e., equal to 
2.71828 . . . , a! is an estimated constant, each of the betas is an estimated 
coefficient, and each x is a risk factor value (as measured at initial examina- 
tion) (3). In the analysis of the Framingham data, the seven risk factors en- 
tered into the equation were: age, serum cholesterol, systolic blood pressure, 
cigarettes smoked per day, relative weight, hemoglobin, and ECG findings. 
For a given age-sex group, the calculated risk values y of all the individuals 
were ranked in order from low to high, and deciles were then identified. For 
each decile, the number of predicted cases of CHD was then determined by 
summing the risks y calculated from the equation for all the persons in the 
decile. For each decile, the actual number of observed CHD cases was also 
tallied, and the observed I2-year incidence rate calculated. These data for the 
2J76 men and t.he 2,669 women age 30-62 and free of CHD at entry are 
presented in Table II (3). Obviously, the method yielded close corre- 
spondence in number of observed and expected cases. Obviously also, the 
method successfully graded both men and women in regard to risk. Based on 
the observed 12-year incidence rates, the ratios of risk for the upper two 
deciles compared with the lower are more than 40: 1 for men and 19: 1 for 
women. 
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Of course, this result was to be expected, since the coefficients generated 
from the Framingham experience itself were then utilized to estimate risk of 
the individuals in this study. The key question really is the generalizability of 
these data. That is, how correctly do these coefficients-derived from the 
Framingham experience -predict risk of other individuals and other popula- 
tions? 
At least two reports are available on applying the risk function developed 
from the Framingham data to the experience of other prospective studies. The 
first was published as part of the recent monograph on 5-year incidence find- 
ings from the International Cooperative Study on the Epidemiology of Car- 
diovascular Disease (4). In this instance, the method was successfully applied 
for prediction of an expected rate for each of the several populations overall, 
and then for a comparison among them, i.e., for an inter-population analysis. 
The correspondence between observed and expected rates for the several 
populations was indeed high, with a correlation coefficient of 0.83. 
Recently, this multiple logistic method and the coefficients from the Fram- 
ingham study were applied to the data from the Peoples Gas Company study 
(7). For this purpose, use was made of the cohort of 1,211 white males age 
40-59 and free of overt CHD at first examination in 1958. This age-race cohort 
is the group from the Peoples Gas Company study entered in the national 
cooperative Pooling Project. For this cohort, data are available concerning in- 
cidence of CHD over the first ten years of follow-up, from 1958-1968. Since 
the coefficients for the Framingham study had been generated based on the 
12-year CHD incidence data, it was deemed most appropriate to apply them 
to the same end point for the Peoples Gas Company men. 
With use of the Framingham coefficients, 12-year risk was computed for 
each Peoples Gas Company man, and the entire cohort was ordered by quin- 
tiles based on predicted risk. Since the Framingham data are based on 12 
years of follow-up, rather than ten, the number of CHD events expected in 
each Peoples Gas Company quintile of risk over 12 years (as generated by the 
equation) was corrected by multiplying by lo/12 or 0.8333, for comparison 
with the actual number of events observed (Table III). As is evident, these 
calculations resulted in reasonably good correspondence between the 
numbers of expected and observed events for the quintiles. Fifty-nine of the 
151 observed events - 39.1% -occurred in the men classified predictively 
in the upper quintile of risk. Ninety-four of the 151 observed events 
-62.3%-occurred in the men classified in the upper two quintiles of risk. 
The ratio of risk for the highest quintile compared with the lowest was 5: 1, 
i.e., predictive power was reasonably good. 
These two initial experiences, international and national, on prediction in 
other populations with use of this method and the Framingham coefficients 
are encouraging, in regard to the key question of generalizability. As these 
methods are more extensively applied, using larger sets of risk factors and ad- 
ditional populations (e.g., those cooperating in the Pooling Project), ability to 
predict risk- i.e., the broad generalizability of these methods-should be 
enhanced. Practitioners of preventive medicine and public health can antici- 
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TABLE III 
APPLICATION OF COEFFICIENTS FROM FRAMINGHAM STUDY 
TO PREDICT TEN-YEAR RISK OF FIRST CHD EVENTS IN 
PEOPLES GAS Co. COHORT OF WHITE MALES AGE 40-59 AND FREE OF 
OVERT CHD AT FIRST EXAMINATION IN 1958 
M.ULT~PLE LOGISTIC METHOD (5) 
Quintile of risk 
No. of men 
at risk 
No. of expected 
events 
No. of observed 
events 
Observed incidence 
rate per 1,000 
1 241 10.9 12 50 
2 244 20.3 18 74 
3 242 31.9 27 111 
4 242 47.7 35 145 
5 241 88.1 59 245 
All 1,211 198.9 151 125 
pate that before long these new practical tools will be made generally avail- 
able, for precise quantitative assessment of risk based on multiple risk factors. 
This should mean a further improvement over present approaches -already 
very useful-for identifying individuals highly susceptible to premature 
atherosclerotic disease. 
HYPERTRIGLYCERIDEMIA- 
HYPERLIPOPROTEINEMIA, HYPERGLYCEMIA, HYPERURICEMIA, OBESITY 
Among the several serum lipids-lipoproteins, cholesterol has been the most 
frequently measured to detect individuals predisposed to CHD. It has been 
amply documented that hypercholesterolemia is associated with grossly 
increased risk. The suggestion has been made that risk can be better pre- 
dicted by measuring levels of serum triglyceride or of lipoproteins. The lim- 
ited amount of data available do not support this view. Reports from prospec- 
tive studies indicate that serum cholesterol is at least as good a predictor as 
any other lipid or lipoprotein measurement, and that none of the others add to 
the predictive power of cholesterol (7). More research is needed in this area. 
At present, particularly for mass screening purposes in communities, serum 
cholesterol measurement is the procedure of choice, especially since it can be 
done without fasting, is subject to less laboratory error than the other proce- 
dures, and is less expensive. For the physician evaluating an individual pa- 
tient in the office, it is useful to collect blood after a 15-hour fast (with the last 
meal low or moderate in fat and free of alcohol), and measure both cholesterol 
and triglyceride, since -if hyperlipidemia is present-availability of both 
measurements assists in guiding treatment. In most cases, there is no need for 
the practitioner routinely to measure serum lipoproteins in addition, whether 
by ultracentrifuge or electrophoresis. If triglycerides are markedly elevated 
and cholesterol less so, there is the outside possibility of a rare familial 
hyperchylomicronemia (either Type I or Type V hyperlipoproteinemia) (8). 
To rule this out, a satisfactory simple procedure is to inspect the fasting serum 
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after it stands overnight in the refrigerator. A cream layer at the top of the 
serum indicates abnormal chylomicronemia, provided the patient was really 
fasting for 15 hours, and his last meal wasn’t laden with fat and alcohol. If the 
infranant is clear, it’s a Type I; if cloudy (lipemic) it’s a Type V-both rare en- 
tities, both treatable by diets low in total fat (less than 10% of calories from fat) 
and (especially for Type V) correction of overweight (9). 
In the general population, the common phenomenon is “moderate” hyper- 
cholesterolemia- either without hypertriglyceridemia, or with hyper- 
triglyceridemia slight moderate or marked but without chylomicronemia. (A 
reasonable cutting point for fasting serum triglyceride abnormality is 150 
mg/dl). Once conditions known to induce hyperlipidemia (e.g., uncontrolled 
diabetes, hypothyroidism, nephrosis, biliary obstruction, pancreatic disease, 
alcoholism, myeloma, contraceptive steroids) have been ruled out, it may be 
concluded that the abnormality is fundamentally diet-induced, i.e., acquired. 
And it can almost always be alleviated by change in diet habit, i.e., to a 
calorie-controlled diet low in saturated fat and cholesterol, moderate (not low) 
in total fat and carbohydrate, moderate (not high) in polyunsaturated fat (7). 
To designate the common hyperlipidemia of Americans as acquired is not to 
say that genetic factors do not operate in them. Since some (a small minority) 
of Americans maintain very low levels of all serum lipids on usual U. S. diets, 
there must be an element of host response in all acquired cases of hyperlipi- 
demia, and almost certainly this often reflects inborn (genetic) differences in 
metabolism. Correspondingly, since almost all persons with familial severe 
hyperlipidemia respond (at least in part) to diet, their condition is to a degree 
environmental in origin and related to the usual U. S. diet. Therefore, the dis- 
tinction between acquired and familial primary hyperlipidemia is relative, 
not absolute. This conclusion in no way contradicts the fact that among 
persons with severe hyperlipidemias in particular, disease usually is due 
predominantly to genetic metabolic abnormalities. 
A practical consequence, for both diagnosis and treatment-of this and 
other risk factors -is the importance of evaluating the entire immediate fam- 
ily. For example, children inherit both their parents’ genes and living habits. 
The latter are amenable to environmental influence. Identification of suscep- 
tibility in a parent must, therefore, immediately call attention to his or her 
children and to parental siblings; the converse is equally true. Hence, preven- 
tion, especially early prevention, is an intrinsic part of family medicine. The 
basic aim is: by changing living habits (the environment)-on a family 
basis-to control hereditable risk factors and thereby mute or negate genetic 
predisposition to premature CHD. This is a key aspect of the strategy of 
focusing on risk factors, to curb the epidemic occurrence of this disease. 
Is control of hyperglycemia -along with the major risk factors-an impor- 
tant aspect of this strategy? For years, clinical diabetes has been recognized as 
a serious risk factor for atherosclerotic disease, although the mechanism is not 
yet well understood. The association between diabetes and coronary, cerebro- 
vascular, and peripheral vascular disease has been extensively documented in 
retrospective studies, clinical and pathologic. Other data confirm that persons 
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with atherosclerotic disease more often manifest abnormal glucose tolerance 
than do control subjects (10,ll). 
Recently population studies have begun to present relevant data in this 
area. The study of DuPont Company employees, involving an average of more 
than 73,000 men and women age 25-64, identified 662 persons with diabetes 
(12). Of these, 418 were normotensive. Their prevalence rate of CHD was 
39% higher than that of randomly selected normotensive nondiabetics - but 
the difference was not statistically significant. In contrast, the 244 hyperten- 
sive diabetics had a CHD prevalence rate nearly double that of hypertensive 
controls-and the difference was highly significant statistically. The question 
arises: Is diabetes an independent CHD risk factor? In a more recent report 
from this study, additional data are presented indicating that clinical diabetes, 
at least, is an independent risk factor (29). 
With respect to asymptomatic hyperglycemia (as distinct from clinical 
diabetes), the Tecumseh study- based on response at one hour to a 1OOg oral 
glucose load given in its first round of examinations-reported an association 
between hyperglycemia and CHD prevalence for both men and women (13). 
The finding was independent of and additive to the effect of serum cholesterol 
and blood pressure. Thus far, this is the only set of data indicating that chemi- 
cal diabetes adds independently to risk. Its suggestive positive findings 
cannot be regarded as resolving the issue, pending both incidence data and 
replication in another study. (The problem in interpreting CHD prevalence 
data is a well-known bugbear of cardiovascular epidemiology.) The Te- 
cumseh study has also reported that its long-term follow-up observations 
show an association between hyperglycemia and incidence of CHD (14). 
However, no data are available as yet to clarify whether this relationship is in- 
dependent of other risk factors. Results from the Framingham study- where 
the measurement was a casual blood glucose determination, without a glucose 
load-suggest that hyperglycemia is not an independent risk factor, not for 
atherosclerotic coronary disease, at least (15). 
The only other set of available prospective data is from the study of middle- 
aged men employed by the Peoples Gas Company in Chicago (7). While that 
investigation was begun in 1958, measurement of glycemia one hour after a 50 
g oral load was done for the first time only in 1965. Several relevant items 
emerged from the initial set of data: Plasma glucose and blood pressure (both 
systolic and diastolic) were significantly correlated, and this relationship held 
up after control for age, relative weight, and thiazide therapy. The higher the 
level of plasma glucose after load, the higher the blood pressure. Men with 
frank hyperglycemia (plasma glucose equal to or greater than 205 
mg/dl- equivalent to whole blood glucose level equal to or greater than 170) 
had a prevalence rate of hypertension of 32% compared to 18% for men with 
glucose levels less than 205. Hyperglycemic men also exhibited higher rates 
of hypercholesterolemia and hyperuricemia. 
For the period 1965-1970, age-adjusted CHD mortality rate was 42 
per 1,000 for the hyperglycemic men, 16 per 1,000 for the normoglycemic 
men. Most of the excess mortality among hyperglycemic men was of men who 
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were also hypertensive. (Hypercholesterolemia and cigarette smoking were 
also implicated.) Numbers of CHD deaths are small so far in these groups, and 
further follow-up is needed over the next years to assess the long-term trends. 
Nevertheless, the data pose important questions: What are the mecha- 
nisms - over and above chronic caloric imbalance -of the associations 
between hyperglycemia and hyperlipidemia, between hyperglycemia and 
hypertension, between hyperglycemia and hyperuricemia? Is a good deal of 
the excess atherosclerosis risk of mild maturity-onset nonketotic non-insulin- 
dependent diabetics in our population a resultant of the concomitant hyper- 
tension and/or hyperlipidemia, and not independently related to the hyper- 
glycemia per se? 
The posing of these questions is not an esoteric exercise in epidemiologic 
dialectics. Very practical issues are involved. Diabetics of this type number 
about 10,000,000 in the U. S. A., and their prime problem far-and-away is risk 
of atherosclerotic “complications.” It is now more than ever clear from the 
results of the University Group Diabetes Program study that treatment of 
hyperglycemia with drugs - oral or parenteral (insulin) -is ineffective in 
averting morbidity or mortality from cardiovascular complications in such 
diabetics (16). Their atherosclerosis is no different in kind-only in de- 
gree-from that of nondiabetics. Therefore a total reconsideration and rede- 
finition is needed of control for such diabetics. Even if for practical purposes 
we assume -or, rather, especially if we assume-that hyperglycemia is an in- 
dependent and additive CHD risk factor for the diabetic, his risk of premature 
atherosclerotic disease is also potently related to his blood pressure, serum 
cholesterol, cigarette smoking- i.e., to the major coronary risk factors. There- 
fore control cannot remain focused narrowly on blood and urine glucose, but 
must become comprehensive. It must include effective control of obesity, to 
correct hyperglycemia and hypertension, as well as attention to fat composi- 
tion of the diet, to correct hyperlipidemia. And cigarette smoking must also be 
corrected. Hope for the prevention of atherosclerotic disease in diabetics lies 
only in such a comprehensive approach to control. 
What about hyperuricemia ? When present (e.g., serum uric acid levels of 
7.0 mg/dl or greater), it is often associated with other factors such as obesity, 
hypertension, and hyperglycemia. Evidence is available that hyperuricemia 
operates as an independent risk factor, but again further clarification is 
needed. 
What then about obesity? For a good many years, it had been taken for 
granted by most people in medicine that obesity-moderate as well as 
marked-predisposed to premature CHD. Presumably, obesity acted as an 
independent risk factor in so doing-although the mechanism was always 
obscure. 
Recently it has become clear that obese persons are more likely to be hyper- 
tensive, hyperlipidemic, hyperglycemic, hyperuricemia. Probably these asso- 
ciations reflect cause-and-effect at work, i.e., chronic caloric imbalance some- 
how contributes to the development of these traits in susceptible people. 
(How is generally ill-defined.) 
But if the obese person is exceptional and is free of these other risk factors, 
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is he still at increased risk? The findings to date are equivocal. It appears that 
in the absence of other risk factors, moderate obesity adds little to risk, but 
this is still open. Very marked obesity is another matter. In any case, obesity 
associated with other risk factors is common, and its correction with a diet of 
optimal fat composition remains an important aspect of controlling the 
obesity-related risk factors. 
HABITUAL DIET HIGH IN CALORIES, SATURATED FATS, CHOLESTEROL 
It is evident-from everything said already- that the habitual diet of Ameri- 
cans may contribute significantly to risk of premature CHD in at least four 
ways -via hyperlipidemia, hypertension, hyperglycemia and hyperuricemia. 
This diet-high in saturated fats and cholesterol-encourages the develop- 
ment of hypercholesterolemia in all with any genetic predisposition, i.e., in 
tens of millions. All too often this diet is also excessive in calories (for level of 
physical activity), so that obesity develops-and as a frequent consequence, 
hypertension, hyperlipidemia, hyperglycemia, hyperuricemia. Therefore, 
this “rich” diet could well be added as a fourth major risk factor to the “big 
three.” 
From a practical point of view, therefore, improvement in eating habits is a 
key part of a rational prophylactic regimen. Obviously, avoiding weight 
gain-or correcting it-can help significantly to prevent or control hyperten- 
sion, hyperlipidemia, hyperglycemia and hyperuricemia in an appreciable 
proportion of the population. And an improved composition of dietary fat in- 
take-as described briefly above, and discussed in detail elsewhere in this 
Symposium - is the key nutritional step qualitatively in the preventive effort. 
SEDENTARY LIFE STYLE (HABITUAL PHYSICAL INACTIVITY, 
LACK OF EXERCISE, 
LOW LEVEL OF CARDIOPIJLMONARY FITNESS) 
Sedentary life style- with resultant poor tiardiopulmonary fitness-has also 
been implicated as a coronary risk factor. While the findings are not as 
clearcut and consistent as for the major risk factors, they are sufficient to war- 
rant concern in developing preventive programs. (Obviously, physical inac- 
tivity is an important contributor to the mass occurrence of obesity in the 
U. S. A., not only among the middle-aged, but also among young adults, teen 
agers and children.) 
Initial data on physical inactivity as a possible risk factor came from Great 
Britain: In relatively homogeneous populations of middle-aged men, coronary 
disease mortality rates over the long term were higher in groups whose work 
involved relatively little physical activity (bus drivers and telephone opera- 
tors) than among others more active (bus conductors and postmen) (17); how- 
ever, there is a suggestion of confounding by preselection of the employee 
groups, i.e., the bus drivers tended to be more obese than the conductors 
when they first went to work as young adults (18). On the other hand, a large- 
scale 5-year study of groups of middle-aged European men was nonconfirma- 
tory (4). Conspicuous are the findings on the cohort of Finns, who consumed a 
CORONARY HEART DISEASE PREVENTION FORUM 43 
diet very high in saturated fat and cholesterol, and were generally very active 
and nonobese. The strenuous character of their work apparently gave little or 
no protection against either hyperlipidemia or CHD, since they were higher 
on both these parameters than U. S. railroad workers (4). 
The most impressive positive data from U. S. studies come from Fram- 
ingham (19). When five indices of activity and fitness were simultaneously 
evaluated-a questionnaire-based scale of total daily activity of work and 
leisure, vital capacity, heart rate, relative weight and hand grip 
strength-persons assessed as more fit had’fewer fatal heart attacks than the 
less fit. This association was independent of serum cholesterol, blood pres- 
sure, and cigarette smoking. 
Therefore, light to moderate exercise, of the type enhancing cardiopul- 
monary fitness (vigorous walking, jogging, bicycling, swimming) may be pro- 
tective - if approached properly to avoid potential hazards - especially when 
combined with reasonable alterations in diet and smoking habits. 
Tachycardia. For years, analyses by life insurance actuaries have indicated 
rapid resting heart rate to be one of the “minor impairments” associated with 
increased risk of cardiovascular and coronary mortality (20). As indicated in 
the preceding section, the Framingham, study has presented data consistent 
with this conclusion (19). So also has the Western Electric study (6~). 
Recently, a detailed analysis of this matter was presented from the Peoples 
Gas Company study (61). Resting heart rates of 80 beats/min or greater at ini- 
tial examination in 1958 were associated with higher lo-year mortality rates. 
This relationship of heart rate to risk was apparently independent of- and ad- 
ditive to-the effects of hypercholesterolemia, hypertension, and cigarette 
smoking. 
These data furnish a further rationale for multifactor prevention pro- 
grams -especially exercise to enhance cardiopulmonary fitness, and cessation 
of cigarette smoking- since both these measures result in slowing of the heart 
rate. 
Personality-behavior patterns, social incongruities, psychosocial tensions. 
Psychosocial tensions related to personal life situations and/or those inherent 
in cultural circumstances have long been suspect as factors related to prema- 
ture CHD. As was noted in the Report on the Primary Prevention of the 
Atherosclerotic Diseases of the Inter-Society Commission for Heart Disease 
Resources, this view has recently received support from several studies (21). 
For example, data from investigations on “high-drive” personality-behavior 
patterns and on social incongruities indicate that these may be significant risk 
factors for premature CHD in our society, independent of and additive to such 
other traits as “rich” diet, hypertension, hypercholesterolemia, cigarette 
smoking and lack of exercise (22,23). Similar data have also been obtained in- 
dicating a detrimental effect of social and geographical mobility and urbaniza- 
tion (24). These various psychosocial influences may be conditioning and/or 
aggravating factors in our society; particularly in the presence of other traits 
enhancing proneness to premature CHD. 
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Most of the positive findings indicating associations between various psy- 
chosocial factors and premature CHD have been recorded in single investiga- 
tions and they require confirmation. Obviously this is understandable in view 
of the complexity of measurement in this area. 
Family history of premature atherosclerotic and/or hypertensive disease. 
Coronary heart disease has long been viewed as related to family history. Evi- 
dence exists indicating an increased risk of CHD in close relatives of persons 
who experience a heart attack early in life, e.g., prior to age 50 (25,26). There 
are numerous examples of multiple premature attacks within families. In con- 
trast, there is little evidence for familial aggregation when the disease first 
occurs late in life. It is likely that much of this predisposition is mediated by 
familial resemblances in key risk factors, e.g., hypercholesterolemia, hyper- 
tension, cigarette smoking (11). Obviously, most of these predisposing influ- 
ences are under both environmental and genetic control. As already noted, 
families share not only genes, but also living habits, e.g., “rich” diet, cigarette 
smoking, sedentary living habit- hence the preventive approach, through 
early detection and control of risk factors, must be a family affair. 
CLINICAL SYMPTOMS AND SIGNS 
Is it reasonable to consider clinical symptoms such as chest discomfort, or 
signs such as lesser electrocardiographic abnormalities as risk factors? Mani- 
festations of this kind certainly cannot be considered “preclinical” warning 
signals, because their presence indicates that clinical disease (if only on a sus- 
pect level) is already present. Yet persons with seemingly minor manifesta- 
tions are at increased risk of developing a “major coronary event,” as defined 
previously! In this sense, lesser symptoms and signs-cardiac precursors of 
major coronary events -can be legitimately considered risk factors (l&27). 
Obviously, there is really no sharp line of demarcation between absence 
and presence of clinically manifest disease. This is well illustrated by stress 
tests. An abnormal electrocardiographic response to exercise is recorded in a 
sizeable proportion of middle-aged American men with normal resting ECGs; 
such men have a several-fold increase in risk of a major coronary event (28). 
Certainly, therefore, such abnormal responses are properly included in the 
spectrum of coronary risk factors. 
CONCLUSION 
The overwhelming weight of evidence implicating the several risk 
factors-especially the major risk factors -makes it mandatory for physicians 
in practice as well as those in public health to incorporate detection in regular 
examinations of adults, including the asymptomatic. There seems little jus- 
tification not to do so, especially since early identification of very high risk 
persons -common in our population - is feasible with use of a few simple, 
familiar, inexpensive procedures. 
In line with what has been learned about the hazards associated with mul- 
tiple risk factors, the Inter-Society Commission for Heart Disease Resources 
also urged development and expansion of community programs (using allied 
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health personnel as well as physicians) to detect and treat persons of all ages 
highly susceptible to premature atherosclerotic disease (1). On the basis of 
recent experience such programs could have a large yield, since fully 20-30% 
of middle-aged adults appear to be at very high risk (1,2). 
The inference is that with identification of persons at risk by such means 
appropriate measures can be taken against controllable risk factors. If reversal 
of atherosclerotic lesions is achievable in primates and other animals by nutri- 
tional means (and a similar approach has reportedly caused regression of 
atherosclerosis in man), surely a prophylactic effort is indicated, with control 
of the major risk factors its cornerstone. For the great mass of the population 
who have not yet experienced a clinical coronary event, the bold goal of 
reversal of lesions need not be set; the more modest ones of stopping or at 
least markedly slowing atherogenesis will suffice. 
As a matter of fact, all the key medical and public health organizations in the 
United States have agreed for years on the need to find the high risk people 
(they with their families number in the tens of millions), and bring them 
under effective long-term care-although precious little has been done so far 
to implement this accepted policy (1). As far as the U. S. population as a whole 
is concerned, some argue that in the absence of “final” proof from mass field 
trials of the relationship of diet to hyperlipidemia and atherosclerotic disease, 
general nutritional-hygienic recommendations to the public as a preventive 
measure would lack authenticity. However, is it not wiser (as the Inter- 
Society Commission Report proposed) to use best judgment based on the 
huge amount of evidence already available, and implement safe measures that 
can probably stem the epidemic-rather than suspend judgment? Since oon- 
temporary living habits render our entire population more or less at risk with 
respect to this disease, it seems entirely fitting to urge the public at large to 
modify living habits in the direction of removing or reducing risk of prema- 
ture coronary disease. Indeed, the Inter-Society Commission emphasized the 
need and propriety of primary prevention measures for the general public (1). 
In recommendations aimed at individual physicians, and health professions 
and policy makers, the Commission called for a three-pronged program: die- 
tary changes to prevent or control hyperlipidemia, obesity, hypertension and 
diabetes; elimination of cigarette smoking; pharmacologic control of elevated 
blood pressure. 
Emphasis on the high risk individual should not deflect concern from 
prophylactic measures aimed at protecting the entire population against the 
large-scale occurrence of premature atherosclerotic disease. Any decision to 
withhold general recommendations to the public on the ground that “final” 
proof of their benefit is not yet at hand must also mean continued acceptance 
of high incidence and mortality rates for coronary heart disease among our 
young adult and middle-aged populations over the next decades. This tolera- 
tion of the coronary epidemic is entirely unnecessary and unjustifiable if one 
accepts, as we believe one must, the scientific evidence as it has been in- 
terpreted and applied in this paper. 
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